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Growing evidence suggests that negative emotions may play a role in the upregulation of innate 
inflammatory processes and associated disease risk. Although the hypothalamic-adrenal-pituitary 
(HPA) axis is believed to play a role in these associations, empirical evidence is mixed. 
Inconsistencies may reflect individual differences in glucocorticoid receptor (GR) sensitivity, the 
capacity of immune cells to respond to anti-inflammatory effects of GC-mediated signaling. We 
examined whether genotypes of a single nucleotide polymorphism (SNP) in the GR gene—GR-
9beta (rs6198), the minor (G) allele of which confers reduced GR sensitivity—moderated 
associations of negative affectivity (NA) and inflammatory activity. Subjects were middle-aged 
men and women of European ancestry participating in two phases of the Adult Health and 
Behavior Project (51% F; 30-54yr). NA was assessed by the neuroticism subscale of the NEO 
Personality Inventory and by the Positive and Negative Affect Schedule. In a subset of 
participants in the second phase of the AHAB project (AHAB-2) (51% F; 30-54yr), peripheral 
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inflammation was additionally assessed by in vitro stimulated production of IL-6, interleukin-
1beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-8 (IL-8), while NA was also 
assessed by ecological momentary assessment. In bivariate and hierarchical regression analyses 
adjusted for potential covariates, none of the NA measures predicted any of the inflammatory 
cytokine levels. However, subjects homozygous for the GR-9β G allele had higher IL-6 levels 
than those of alternate genotypes after adjustment for age, gender, and years of school (β = .057, 
p = .045, R2 = .047). Although GR-9β genotype was not associated with any of the stimulated 
cytokines, the interaction of GR-9β was significant, and showed that greater PANAS NA scores 
associated with greater IL-1β levels, but only among G allele homozygotes (β = .127, p = .027, 
∆R2 = .015). While these results raise the possibility that GR-9β G allele homozygotes show 
increased inflammatory susceptibility to negative emotionality, this pattern was not retained in 
analyses of circulating IL-6, or stimulated production of IL-6, TNF-α, and IL-8. We found 
limited evidence that genotypes of the GR-9β polymorphism moderated associations of NA and 
measures of peripheral inflammation. 
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1.0  INTRODUCTION 
1.1 PSYCHOLOGICAL FACTORS AND CHRONIC DISEASE 
Accumulating evidence shows that psychological factors play a role in determining overall 
health and susceptibility to disease. For example, it is now widely accepted that psychosocial 
factors including depressive symptoms and hostile dispositions predict cardiovascular disease 
morbidity and mortality (reviewed by Celano & Huffman, 2011; Suls, 2013), and that 
psychological stress predicts susceptibility to and course of infectious disease (Pedersen, 
Zachariae, & Bovbjerg, 2010). Recent research attention has focused on identifying 
psychobiological pathways that contribute to these relationships. In this regard, growing 
evidence shows that the immune system is one pathway by which psychosocial factors  “get 
under the skin” to influence disease susceptibility. Inflammation is an innate immune process 
that promotes recovery from acute infection and injury and is thought to pay a key role in the 
association of psychosocial factors with disease risk.  Activation of inflammatory processes are 
adaptive in the short-term; however, chronic inflammation is known to contribute to the 
pathogenesis and course of many chronic diseases of aging, including cardiovascular disease, 
diabetes, autoimmune and neurodegenerative diseases (e.g. Alzheimer’s disease), and certain 
cancers (Gorelick, 2010; Grivennikov, Greten, & Karin, 2010; Libby, 2008; Zeyda & Stulnig, 
2009). Interestingly, these same diseases are associated with psychosocial risk, raising the 
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possibility that psychological processes may modulate disease risk by increasing inflammatory 
activity. 
 
1.2 THE ROLE OF INFLAMMATION  
To date, the majority of studies assessing the role of inflammation in psychologically-related 
disease risk have focused on circulating levels of proinflammatory mediators, including the 
cytokines interleukin (IL)-1, tumor necrosis factor-α (TNF-α), and IL-6. Locally, these cytokines 
are released by activated monocytes and macrophages in response to infection or injury and 
serve several functions, including stimulating the expression of epithelial adhesion molecules, 
increasing vascular permeability, and supporting leukocyte trafficking through chemotactic 
signaling. Proinflammatory cytokines also enter the peripheral circulatory system, and are 
involved in signaling a systemic inflammatory response. For example, IL-6 stimulates the 
production of acute phase proteins, such as C-Reactive Protein (CRP), by hepatocytes. It is 
widely accepted that circulating concentrations of IL-6 and CRP provide a marker of level of 
systemic inflammation.  
While cytokine responses are vital to the coordination of immune responses that manage 
and eliminate invading pathogens, excessive and prolonged responses impose significant 
metabolic demand (Lochmiller & Deerenberg, 2000) and increase the potential for collateral 
damage and risk for chronic inflammatory disease (Finch, 2009). For this reason, magnitude of 
acute inflammatory response is tightly regulated by local and systemic negative feedback 
mechanisms. Locally, the release of proinflammatory cytokines from monocytes/macrophages 
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stimulates the production of anti-inflammatory cytokines, including IL-10, which act on IL-10 
receptors on monocytes to shut down the inflammatory response. Increased circulating levels of 
peripheral inflammatory cytokines are also detected by the brain (reviewed by Dantzer, 
O'Connor, Freund, Johnson, & Kelley, 2008) and result in activation of the HPA axis and the 
release of glucocorticoids (GC’s) from the adrenal cortex. GC-mediated signaling in the 
macrophages/monocytes results in the downregulation of peripheral inflammatory responses 
(reviewed by Sapolsky, Romero, & Munck, 2000), and thus provides a systemic mechanism for 
down-regulating peripheral inflammation.  
 
1.3 ISSUES IN THE MEASUREMENT OF INFLAMMATION 
Although it is widely accepted that circulating cytokines reflect an index of immune-derived 
inflammatory activity at the time of the blood draw, proinflammatory cytokines are released by a 
number of different cell types including endothelial cells and adipocytes, with adipocytes 
contributing 10-35% of total circulating IL-6 (Mohamed-Ali et al., 1997). Thus, it is possible that 
the inflammatory mediators that are detectable in peripheral circulation originate from non-
immune sources, such as adipose tissue.  In order to more directly examine the possibility that 
psychological factors impact innate immune processes, some studies have turned to an in vitro 
examination of the functional ability of immune cells to produce proinflammatory cytokines 
when exposed to immune stimulants. This provides a more direct method of capturing individual 
differences in the magnitude of inflammatory response, a process that is typically localized in 
vivo and may not be detectable using traditional systemic approaches. Furthermore, by 
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stimulating leukocytes with a ligand that activates specific leukocyte subsets, a higher degree of 
immune specificity is achieved. For example, lipopolysaccharide (LPS), a component of the 
extracellular matrix in gram-negative bacteria stimulates toll-like receptor 4 (TLR4), a surface 
receptor found predominantly on monocytes. LPS activation of TLR4 results in the expression of 
several proinflammatory cytokines including IL-6, TNF-α, and IL-1 beta (IL-1β). Individuals 
vary considerably in the magnitude of proinflammatory cytokine production in response to LPS, 
and that this variability is temporally stable (Wurfel et al., 2005). Thus, individual differences 
may reflect a stable propensity of the individual to mount an inflammatory response in the face 
of pathogenic challenge. The existence of such stable characteristics makes it conceivable that 
there is a meaningful distribution of differences in cytokine production that may form a 
physiological basis for associations between psychosocial factors and risk of inflammatory 
disease. 
1.4 FACTORS ASSOCIATED WITH INDIVIDUAL DIFFERENCES IN 
INFLAMMATION 
The negative health sequelae associated with chronic inflammation have stimulated interest in 
understanding its determinant and moderating factors. Currently, it is recognized that genetic 
factors play a significant role, with heritability estimates of LPS-stimulated IL-6, TNF-α, and IL-
1b being 57%, 53%, and 86% respectively (de Craen et al., 2005). Although the other 
determinants of stimulated cytokine production are largely unknown, some studies have shown 
positive associations of LPS-stimulated cytokine production with age, male gender, and 
inflammatory disease status (Aulock et al., 2006; Nakamura, Saito, Kasanuki, Tamura, & 
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Yoshida, 1992), but not all results are consistent (Gardner & Murasko, 2002). Similarly, age, 
socioeconomic status (SES), adiposity, and physical activity are robust covariates of systemic 
inflammation (O'Connor, Motivala, Valladares, Olmstead, & Irwin, 2007; Worns, Victor, Galle, 
& Hohler, 2006). In addition, growing evidence suggests that psychosocial factors, particularly 
those associated with chronic psychological stress, may play an independent role (Hansel, Hong, 
Camara, & von Kanel, 2010). Here, a large body of literature shows an association of 
psychosocial risk factors, including chronic stress, lower SES, loneliness, and childhood 
adversity, with increased circulating markers of inflammation (e.g. Alley, Crimmins, 
Karlamangla, Hu, & Seeman, 2008; Danese, Pariante, Caspi, Taylor, & Poulton, 2007; Kiecolt-
Glaser et al., 2003). 
In addition to studies that show associations of stressful life situations with elevated 
inflammation, accumulating evidence suggests that individual characteristics, particularly 
negatively valenced emotional dispositions, such as depression, anxiety, anger, and hostility, 
covary positively with markers of systemic inflammation. For example, epidemiologic studies 
have shown that depressive symptoms and trait hostility predict increases in systemic IL-6 over a 
6-year period of adulthood (Stewart, Rand, Muldoon, & Kamarck, 2009), and that greater 
depressive symptomatology at the time of a cardiac event predicts smaller decreases in CRP one 
month later (Shaffer et al., 2011). Laboratory studies also show that negative emotional 
responses to an acute stressor predict magnitude of task-related increases in IL-6 (Carroll et al., 
2011), and that hostile individuals display greater post-stress elevations in IL-6 as compared to 
their less-hostile counterparts (Brydon et al., 2010). Taken together, evidence from 
epidemiologic and laboratory-based approaches links negative emotions to increased peripheral 
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inflammatory activity, raising the possibility that inflammation contributes to the risk for 
inflammatory disease that accompanies chronic stress and negative emotions. 
The range of negative affective characteristics that accompany elevated inflammatory 
activity raises the possibility that an underlying factor reflecting common variance between these 
psychological constructs may play an active role. Supporting this notion, confirmatory factor 
analyses have shown that a single latent factor accounts for a substantial amount of variability 
common to individual negative emotions including fear, anger, guilt, and sadness (Watson & 
Clark, 1999). This shared variance is conceptualized to be trait Negative Affectivity (NA), 
reflecting individual differences in the propensity to experience negatively valenced affects (e.g., 
fear, anger, sadness, and anxiety), and is believed to contribute to shared health risks (Suls & 
Bunde, 2005; D. Watson & Clark, 1984). NA is a central component of the trait commonly 
labeled Neuroticism (or Negative Emotionality) in several taxonomies of personality and these 
traits may further reflect vulnerability towards feelings of general distress (Brief, Burke, George, 
Robinson, & Webster, 1988). To date, only one study conducted by Bouhuys, Flentge, 
Oldehinkel, and van den Berg (2004) has investigated associations stimulated cytokine 
production with a global construct of NA. Although individuals higher in negative emotionality 
showed greater in vitro production of IL-6 production in this study, current literature on 
associations of systemic inflammation and NA is mixed. For example, results of a recent study 
show that among 4923 individuals of varying ages (14-82 years), scores on the neuroticism 
subscale of the NEO Personality Inventory were positively associated with systemic levels of IL-
6 (Sutin et al., 2010). Conversely, Nabi et al. (2008) show an association of trait NA with 
incident coronary heart disease over an approximately 10 year period, but no association with 
circulating levels of CRP or IL-6. 
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Reasons for inconsistences in the available literature linking NA with elevations in 
peripheral inflammatory activity are unclear. Given that infectious disease has driven the 
evolution of the immune system (Finch, 2009), it is plausible that a particularly plastic immune 
system that responds to environmental threat and associated negative emotional states by priming 
innate inflammatory mechanisms confers survival advantage in the face of acute challenge. 
Although beneficial in this capacity, an increased propensity towards inflammation may be 
detrimental in the long-term, contributing to the increased risk for inflammatory-related disease. 
In this regard, a malleable inflammatory phenotype with the capability to respond across a range 
of emotional experiences may confer a selective advantage in environments characterized by 
acute challenge, while simultaneously conferring a disadvantage among individuals who are 
disposed to negative emotional states. In light of these evolutionary forces, it is conceivable that 
there are individual differences in inflammatory susceptibility to negative emotional experience 
are heritable—a possibility that remains uninvestigated. The failure to consider the role of 
genetic factors that moderate the magnitude of these relationships may account for inconsistent 
findings the literature investigating associations of NA and inflammation. 
1.5 PATHWAYS LINKING NA TO INFLAMMATION: THE HYPOTHALAMIC-
PITUITARY-ADRENAL AXIS 
One of the primary biological pathways connecting the brain to the immune system is the HPA 
axis, which is activated under conditions of psychological stress. Activation of this pathway 
begins in the hypothalamus with the release of arginine vasopressin and corticotropin releasing 
hormone (CRH) from the paraventricular nucleus into the pituitary portal vein system. This 
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signal stimulates release of adrenocorticotropin releasing hormone (ACTH) from the anterior 
pituitary into general circulation, ultimately resulting in the peripheral release of GC’s from the 
adrenal cortex. In humans, the chief GC secreted by the adrenal cortex is cortisol. In the absence 
of external demands, cortisol follows a diurnal pattern of secretion characterized by an initial 
morning rise, peaking around 30 minutes after awakening, and a decline throughout the day, 
falling to a nadir in the evening hours (Kirschbaum & Hellhammer, 1989). 
It is widely accepted that GCs play an anti-inflammatory role in the peripheral immune 
system. By binding to intracellular glucocorticoid receptors (GR’s) expressed in monocytes, 
lymphocytes, neutrophils, and macrophages, GCs orchestrate several intracellular pathways that 
down-regulate proinflammatory gene expression among other physiologic processes (reviewed 
by Barnes, 2011). Indeed, it is believed that 20% of genes expressed in human leukocytes are 
controlled by GC signaling (Galon et al., 2002). Among these gene-regulatory effects, it is well 
characterized that GC receptor activation elicits inhibition of NF-κB, a potent transcriptional 
activator that promotes TNF-α, IL-1, and IL-6 gene induction (reviewed by Sapolsky et al., 
2000), thus leading to a decrease in inflammatory activity. GC receptor signaling has also been 
shown to influence cell trafficking, trigger apoptosis of immature T and B cell precursors, and 
modulate cell adhesion molecules necessary for the localized inflammatory response (Cronstein, 
Kimmel, Levin, Martiniuk, & Weissmann, 1992; van de Stolpe, Caldenhoven, Raaijmakers, van 
der Saag, & Koenderman, 1993). Thus, cortisol plays a key physiologic role in the down-
regulation of peripheral inflammatory responses. For this reason, GC’s are clinically 
administered in the treatment of inflammatory disease (Barnes & Adcock, 2009). 
It is generally accepted that negative emotional dispositions modulate activity of the HPA 
axis. Supporting this notion, several studies show elevated diurnal cortisol secretion in trait 
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negative individuals as compared to their more positive peers (e.g. Nater, Hoppmann, & Klumb, 
2010; Polk, Cohen, Doyle, Skoner, & Kirschbaum, 2005; Portella, Harmer, Flint, Cowen, & 
Goodwin, 2005; Wetherell et al., 2006), but not all findings are consistent (e.g. Hauner et al., 
2008; Schommer, Kudielka, Hellhammer, & Kirschbaum, 1999). Reasons for discrepant findings 
are unclear, but it has been suggested that temporal factors may play a role, with chronic stress 
eliciting an initial upregulation of HPA axis activity that is followed by a rebound to levels that 
are below normal (Miller, Chen, & Zhou, 2007). Thus, it is plausible that inconsistent 
associations of trait NA with cortisol levels reflect physiologic adaptation in response to 
persistent negative emotion. Recent evidence suggests that this adaptation involves down-
regulation of the sensitivity of GC receptors, which may play a greater role in modulating health-
related physiologic processes than absolute hormone levels per se (Cohen et al., 2012; Miller, 
Cohen, & Ritchey, 2002). 
Given that GC’s downregulate inflammation, elevations in inflammatory activity that 
have been shown to accompany NA appear paradoxical unless the role of GC sensitivity is 
considered. Here, it is proposed that chronic stress and negative emotional traits are accompanied 
by decreased GR sensitivity, possibly reflecting an adaptation to initially raised levels of cortisol 
(Miller et al., 2002). Early support for stress-related GC resistance came from murine models 
showing that when compared with rats kept in a stable social situation, rats exposed to the stress 
of frequent social disruptions (SDR) displayed decreased GC sensitivity of splenocytes, resulting 
in exaggerated immune responses to LPS (Stark et al., 2001). In parallel with murine studies, 
evidence for GC resistance has been found among non-human primates that show nervous 
temperaments (Capitanio, Mendoza, & Cole, 2011). In humans, consistent evidence shows an 
association of chronic stress with GC resistance. Here, evidence of GC resistance has been 
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shown in parents of children with cancer, spousal caregivers of patients with brain cancer, and 
individuals endorsing chronic psychological stress, social isolation, loneliness, vital exhaustion, 
and low SES (Bauer et al., 2000; Cohen et al., 2012; Cole, 2008; Corwin et al., 2013; Miller et 
al., 2002; Wirtz et al., 2003). Although the precise mechanism precipitating GC resistance is 
unclear, these findings raise the possibility that psychological factors including negative 
emotionality may play a role in modulating the functional propensity of target tissues to respond 
to cortisol. To the extent that activation of the HPA system assists in the down-regulation of 
inflammatory activity that accompanies NA, it is possible that diminished GR function may 
confer a subsequent increase in both immune-derived and systemic inflammatory activity. 
1.6 THE POSSIBLE ROLE OF GENETIC FACTORS: THE GR-9 
POLYMORPHISM 
In addition to environmental challenge, recent studies suggest that genetic variability may 
contribute to individual differences in GC sensitivity. Functional polymorphic variation in the 
GC receptor is associated with clinical outcomes among those with inflammatory diseases, 
including rheumatoid arthritis, multiple sclerosis, cardiovascular disease, and asthma (Otte et al., 
2010; Panek et al., 2012; van den Akker et al., 2008; van Winsen et al., 2009). Although fewer 
gene-linkage studies have focused on inflammation, evidence suggests that variation in a single-
nucleotide polymorphism (SNP) in the glucocorticoid receptor gene (NR3C1), commonly 
referred as GR-9β (rs6198), may contribute to individual differences in GR sensitivity. 
Molecular studies show that the GR-9 minor G allele confers a stabilization of GR-β mRNA, 
the protein isoform of which reduces the capacity for cortisol to elicit its typical gene-regulatory 
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effects, including typical trans-repression of the pro-inflammatory genes (Kino, Su, & Chrousos, 
2009; Oakley & Cidlowski, 2011). Thus, it is proposed that the GR-β isoform contributes to GC 
resistance and elevated peripheral inflammation (Li, Leung, Hall, & Goleva, 2006; van den 
Akker et al., 2006). In support of this possibility, studies show elevated GR- mRNA expression 
in leukocytes from individuals with GC resistant forms of asthma, rheumatoid arthritis, and 
Crohn’s disease (Goecke & Guerrero, 2006; Honda et al., 2000; Kozaci, Chernajovsky, & 
Chikanza, 2007; Sousa, Lane, Cidlowski, Staynov, & Lee, 2000). Particular significance of the 
GR-9β G allele in inflammatory disease has been demonstrated in studies of cardiovascular 
disease, rheumatoid arthritis, hypertension, and depression (Chung et al., 2009; Derijk et al., 
2001; Koeijvoets et al., 2008; Otte et al., 2010; Szczepankiewicz et al., 2011). For example, a 
study conducted by van den Akker et al. (2008) showed higher levels of circulating IL-6 and 
CRP among homozygote GR-9β G allele carriers as compared to individuals of alternate 
genotypes. In this study, G allele homozygotes also displayed greater carotid-intima thickness, a 
subclinical measure of arterial atherosclerosis, along with increased risk for coronary heart 
disease and myocardial infarction. In vitro, the GR-9β G allele is also associated with increased 
resistance to dexamethasone suppression of IL-2 expression (van den Akker et al., 2006). Taken 
together, these converging findings suggest that polymorphic variation in NR3C1 may play a 
functional role in individual differences in GC sensitivity. Consistent evidence shows that GR-9β 
G allele confers a decrease in GR function, which manifests as an increase in peripheral 
inflammatory activity. 
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1.7 THE CURRENT STUDY 
Given that GC signaling normally assists in terminating the inflammatory cascade, diminished 
GR function is likely to manifest as an overall increase in inflammation, particularly in situations 
necessitating HPA activation in the down-regulation of inflammatory activity. To the extent that 
negative emotions elicit an increase in peripheral cortisol levels, it is possible that HPA-axis 
activation and GR sensitivity may play a role in the regulation of inflammatory activity that 
accompanies NA. Although diminished GR function conferred by the GR-9β G allele may exert 
a genetic main-effect on inflammatory activity, it is further plausible that this allele may manifest 
particularly among individuals high in NA, where recruitment of the HPA system is believed to 
play a role in the down-regulation of inflammation. Thus, the current study provides an initial 
investigation of whether NA covaries with peripheral inflammation as a function of polymorphic 
variation at the GR-9β locus. Accordingly, the specific aims were: 
Specific Aim 1: To assess associations of dispositional NA with peripheral inflammatory 
activity, measured as circulating IL-6 levels and in vitro lipopolysaccharide (LPS)-stimulated 
production of proinflammatory cytokines: IL-6, IL-8, TNF-α, and IL-1β. Based on existing 
evidence (e.g. Marsland, Prather, Petersen, Cohen, & Manuck, 2008; Marsland, Sathanoori, 
Muldoon, & Manuck, 2007; Sutin et al., 2010), it was hypothesized that trait NA would be 
positively associated with circulating IL-6 and magnitude of proinflammatory response. 
Specific aim 2: To examine associations of the GR-9β polymorphism with inflammation. 
Prior studies show elevated levels of systemic inflammation among GR-9β G allele homozygotes 
(Otte et al., 2010; van den Akker et al., 2008). Thus, it was hypothesized that the GR-9β G allele 
would be associated with higher circulating IL-6 and stimulated production of proinflammatory 
cytokines. 
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Specific aim 3: To Investigate whether associations between dispositional NA and 
proinflammatory cytokines are moderated by allelic variation at the GR-9β locus. It was 
hypothesized that the magnitude of association between NA and markers of inflammation would 
be greater among GR-9β G homozygotes as compared to individuals of alternate genotypes. 
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2.0  METHODS 
2.1 SAMPLE 
Study data were derived from two samples of mid-life community adults recruited via mass-mail 
solicitation from Southwestern Pennsylvania (primarily Allegheny County) who participated in 
the University of Pittsburgh Adult Health and Behavior (AHAB) projects. Similar information 
was collected on participants in both projects, providing a compendium of behavioral and 
biological measurements, including socio-demographic measurements; indices of personality, 
temperament, and psychopathology; health-impairing attributes of habit and lifestyle; biological 
measurements germane to cardiovascular, metabolic, endocrine, autonomic, immune, and central 
nervous system functioning; and DNA for the study of genetic variation associated with registry 
phenotypes. The AHAB-1 project recruited a total of 1,379 participants between the ages of 30 
to 54 years. Exclusion criteria for this sample included: age <30 or >54 years; a reported history 
of atherosclerotic cardiovascular disease, chronic kidney or liver disease, cancer treatment in the 
preceding year, and major neurological disorders, schizophrenia, or other psychotic illness. 
Participants were also excluded if they were using insulin and glucocorticoid, antiarrhythmic, 
psychotropic, and prescription weight-loss medications. Other exclusion criteria included 
pregnancy and working nightshifts exclusively. The AHAB-2 project included 490 participants. 
In addition to exclusion criteria employed in AHAB-1, the AHAB-2 study also excluded 
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individuals taking fish-oil, DHA supplements, or the fat blocker Alli; those with reading skills 
below the 8th grade level; shift workers; and persons whose employment situation would not 
permit momentary interruptions required for electronic diary and ambulatory data collection. 
Because the AHAB-2 study included an fMRI assessment, individuals were also excluded if they 
were claustrophic; had metal objects in or on the body that could not be removed; or if their body 
habitus would not permit them to fit into the MR scanner. Data collections in both phases of the 
AHAB study occurred over multiple laboratory sessions and informed consent was obtained in 
accordance with approved protocols and guidelines of the University of Pittsburgh Institutional 
Review Board. 
Given that allele frequencies in the glucocorticoid receptor differ between ethnic groups 
(e.g. Hawkins et al., 2004), the current study analyses were limited to the non-Hispanic 
Caucasian participants in both studies. Out of the total available sample of 1,869 participants, 
1,500 were non-Hispanic Caucasians (1099 and 401 participants in AHAB-1 and AHAB-2, 
respectively). For circulating IL-6 measures, data were aggregated across both phases of the 
AHAB project. Among the combined sample of 1,500 participants, 173 were excluded due to 
history of chronic inflammatory disease (hepatitis, asthma, and/or rheumatoid arthritis) or use of 
inhaled corticosteroids, and 33 participants were excluded for endorsing signs of acute infection 
at the time of the blood draw. For circulating measures, 57 additional individuals with serum IL-
6 concentrations above 10pg/mL were excluded from analyses, due to heightened likelihood of 
an acute inflammatory process, creating a final sample of 1237 individuals. Stimulated cytokine 
assays were only conducted in AHAB-2. Of the 401 non-Hispanic Caucasians in that sample, 33 
individuals were excluded due to chronic inflammatory-related disease or inhaled corticosteroid 
use, creating a final sample of 368 individuals. 
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2.2 GENOTYPING 
The GR-9β SNP was amplified using unique sequence primers, and genotyped by the 
fluorescence method of Chen et al. (1999). Forward and reverse primer sequences were 
CCTACGCAGTGAAATGTC and CAGATTGGACAATCGGAAC respectively.  Genotypes 
were assigned by direct comparison to sequence confirmed genotypes of each genotype.  A 5% 
resample was genotyped independently to check for reproducibility, and all genotypes were 
confirmed. 
2.3 NEGATIVE AFFECTIVITY 
A number of measures of trait NA were available in AHAB-1 and AHAB-2. In both samples, 
measures included the NEO Personality Inventory (NEO-PI-R; Costa & MacCrae, 1992) and the 
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen 1988). In addition, 
for AHAB-2 only, participants completed an electronic diary across 4 days, which included 
momentary assessment of 7 negative affective states, which were averaged to produce an index 
of trait affectivity. 
 The NEO-PI-R consists of 240-items designed to measure 5 broad domains—
neuroticism, extraversion, openness, agreeableness, and conscientiousness—that are believed to 
reflect the basic structure of personality. For each item, participants were asked to indicate their 
level of agreement (1=strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree). Sum 
scores for the neuroticism domain were computed, comprised of 6 facets including anxiety, 
angry hostility, depression, self-consciousness, impulsiveness, and vulnerability to stress. 
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Supporting the notion that these facets may reflect a common construct of NA, internal 
consistency of the neuroticism domain is high, with reliability coefficients ranging form .89-.95 
in non-psychiatric populations (Costa, McCrae, & Dye, 1991). Validity of the neuroticism 
domain has been demonstrated by its association with similar constructs and convergence with 
peer reports  (Costa & McCrae, 1992; McCrae & Costa, 1987). 
The PANAS is a 60-item adjective checklist believed to reflect general positive and 
negative affective tendencies (Watson & Clark, 1984). The negative affect scale is comprised of 
10 items: afraid, scared, nervous, jittery, irritable, hostile, guilty, ashamed, upset, and distressed. 
Here participants were instructed to rate each adjective on a 1-5 scale describing how they 
generally feel, and sum scores were computed. Internal consistency of the PANAS NA scale is 
high (reliability coefficients ranging from .85-.93), and construct validity has been shown by 
convergence with peer report (Watson & Clark, 1999). 
 In addition to the paper and pencil scales, participants in AHAB-2 completed an 
electronic diary each hour after awakening across 4 separate days (3 work days and 1 weekend 
day) during a 2-week period. On each occasion, the diary included 7-adjectives taken from the 
PANAS that assessed current negative mood: upset, hostile, nervous, afraid, angry, lonely, and 
sad (David Watson et al., 1988). Participants were required to rate the extent that each item 
described their current mood on a 7-point Likert scale, ranging from 0 (not at all accurate) to 6 
(extremely accurate). The use of aggregated EMA data to characterize individual differences in 
NA may present and advantages over traditional retrospective self-report questionnaires 
administered in laboratory settings (Shiffman, Stone, & Hufford, 2008). For example, it is well 
established that retrospective recall can be inaccurate (Bradburn, Rips, & Shevell, 1987) and 
recall concerning affective dispositions is likely influenced by current affective states. These 
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issues are minimized with EMA, where participants make momentary, real-time assessments of 
current affect. Additionally, the use of repeated assessments over several days may provide a 
more accurate characterization of subjects’ “typical” state than single measurement occasions. 
However, the extent that mood over a 4-day period represents more stable affective 
characteristics is unclear. 
2.4 PROCEDURES 
Blood samples for measurement of circulating levels of IL-6 and stimulated production of 
inflammatory cytokines were collected on a different day 2-4 weeks before the assessment of 
NA. On this occasion, participants were asked to fast for 8 hours, to avoid exercise for 12 hours, 
and alcohol for 24 hours before coming into the laboratory. Blood was drawn through antecubital 
venipuncture into sodium-heparin treated Vacutainer tubes and serum separator tubes during 
morning hours. 
2.5 SERUM IL-6 ASSESSMENT 
Serum IL-6 concentrations were determined using a high sensitivity quantitative sandwich 
enzyme immunoassay kit (R&D Systems) according to manufacturer’s directions. The assay 
standard range is 0.156 to 10 pg/mL. IL-6 levels were extrapolated from a standard curve with 
linear regression from a log-linear curve. Log transformation was applied to normalize raw score 
distributions of circulating IL-6 values. 
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2.6 STIMULATED CYTOKINE PRODUCTION AND MULTIPLEX ASSAY 
Whole blood was diluted 10:1 in saline solution, and stimulated with LPS at a final concentration 
of 2.5ug/mL under sterile conditions and incubated at 37 degrees Celsius with 5.0% CO2 for 24 
hours. Blood was then centrifuged at 1000g for 10 minutes and plasma was frozen at -80 degrees 
Celsius for batch analysis. Following study completion, samples were assayed using a multiplex 
analysis system. Multiplex bead kits (Biosource, Camarillo, CA), based on the principle of solid 
phase sandwich immunoassays, were employed and stimulated levels of IL-6, IL-1β, TNF-α, and 
IL-8 were determined using Bio-Plex Manager Software (Bio-Rad Corporation, Hercules, CA), 
interpolating from a standard curve (Logistic-5PL curve fit). Levels of stimulated cytokines fell 
within the range of reliable detection for 332, 330, 327, and 292 individuals on assessment of IL-
1β, IL-6, TNF-α, and IL-8, respectively. To normalize raw score distributions, log 
transformations were applied to stimulated IL-6 and IL-8 concentrations. Square root 
transformations were applied to stimulated IL-1β and TNF-α values. 
2.7 ROLE OF DEMOGRAPHICS AND LIFESTYLE FACTORS 
Several biobehavioral covariates that might confound associations of NA and inflammatory 
activity were assessed. These variables included age, sex, years of formal schooling, body mass 
index (BMI), physical activity, and smoking status. Here, the Paffenbarger Physical Activity 
Questionnaire (Paffenbarger, Blair, Lee, & Hyde, 1993) was used to provide an indicator of 
physical activity. Height and weight data collected at the time of blood draw were utilized to 
compute BMI scores, and self-report data were used to determine age, years of school, and 
  20 
smoking status. To normalize raw distributions, BMI and physical activity scores were log and 
square root transformed respectively. 
2.8 ANALYTIC STRATEGY  
Specific Aim 1: Hierarchical linear regression was used to examine associations of NA with the 
inflammatory measures. Demographic characteristics (age, sex, years of school) were entered in 
step 1, followed by the different measures of NA in a second step of separate models predicting 
the inflammatory outcomes. Additional analyses examined whether lifestyle factors (BMI, 
physical activity, smoking status, and alcohol use) contributed to any variance in inflammatory 
factors associated with NA. 
 Specific Aim 2: To determine whether inflammatory measures covaried with GR-9β 
genotype, a series of hierarchical regression analyses was conducted, comparing 1) GG 
individuals against a combined GA and AA group, 2) a combined GG and GA group against AA 
individuals, and 3) all three genotypes in an additive G allele model. To initially determine 
whether any of the relevant participant demographics (age, gender, years of school) and lifestyle 
factors (BMI, physical activity, smoking status, and alcohol consumption) varied by genotype, a 
series of analysis of variance, Chi-squared, and t-tests were conducted for each genotype 
comparison. In analyses of NA, genotype terms were entered in step 2, with age, gender, and 
years of school entered in step 1 of separate models predicting the different inflammatory 
measures. 
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 Specific Aim 3: To address the possibility that associations of NA and inflammatory 
activity covary as a function of GR-9β genotype, hierarchical regression was utilized. For these 
analyses, NA and genotype scores were centered to reduce potential collinearity issues. Age, 
gender and years of school were entered in step 1 of the model, with genotype and NA scores 
entered in step 2, and the interaction product terms entered in step 3. Analyses were again 
repeated adjusting for lifestyle factors as well as demographics in step 1. 
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3.0  RESULTS 
3.1 DEMOGRAPHIC CHARACTERISTICS AND LIFESTYLE FACTORS 
For both phases of the AHAB project (AHAB-1 and AHAB-2), demographics and lifestyle 
factors are reported in Table 1. Participants in AHAB-1 were older, less educated, and less 
physically active than their AHAB-2 counterparts. For this reason, subsequent analyses of 
circulating IL-6 in the combined dataset were conducted with the inclusion of study phase 
(AHAB-1 vs. AHAB-2) as a covariate. 
3.2 AIM 1: DOES NEGATIVE AFFECT COVARY WITH MEASURES OF 
INFLAMMATION? 
3.2.1 Stimulated cytokines & negative affect 
In Aim 1, it was hypothesized that NA would positively covary with stimulated production of IL-
6, IL-1β, TNF-α, and IL-8 levels. Bivariate correlations among study variables are reported in 
Table 2. Simulated levels of IL-6, TNF-α, and IL-1β were highly intercorrelated (r’s = .58-.80). 
Stimulated IL-8 associated positively with IL-6 (r = .14), and inversely with IL-1β and TNF-α  (r 
= -.18; r = -.20, respectively). Stimulated levels of all three proinflammatory cytokines were 
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inversely associated with age (r’s = -.15 - -.18), and lower levels of IL-6 and TNF-α were found 
in females (r’s = -.26 & -.14 respectively). Higher IL-8 was associated with fewer years in 
school (r = -.13), higher BMI (r = .14), male sex (r = -.14), and current smoking (r = .14). Scores 
on the different measures of NA (NEO Neuroticism, PANAS NA, and EMA NA) covaried 
significantly (r’s = .34 - .66). However, no significant bivariate associations of stimulated 
proinflammatory cytokine concentrations with NA measures were observed. 
To investigate the possibility that NA may relate to stimulated cytokine levels 
independently of demographics and lifestyle factors, a series of regression analyses were 
conducted. No independent associations between any of the NA measures and cytokine 
production was seen in models that controlled for demographic characteristics (age, gender, 
years of school) alone or for demographic characteristics and lifestyle factors (BMI, physical 
activity, current smoking status, and alcohol use; Table 3). 
3.2.2 Circulating IL-6 & negative affect 
It was hypothesized that NA would covary positively with circulating levels of IL-6. In the 
combined sample of 1237 individuals with reliable IL-6 measures, bivariate correlations between 
study variables are reported in Table 4. Consistent with prior literature, higher circulating IL-6 
was associated with older age (r = .13, p < .01), higher BMI (r = .35, p < .01), fewer years of 
school (r = -.16, p < .01), physical inactivity (r = -.18, p < .01), and current smoking (r = .11, p 
< .01). In the larger sample, an association of NEO Neuroticism and PANAS NA scores was 
observed (r = .65 p < .01). However, neither was significantly associated with circulating IL-6 
concentration in bivariate analyses or in multivariate models that adjusted for demographics and 
lifestyle factors (Table 5). In the smaller sample whom EMA data were available, circulating IL-
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6 levels showed no significant association with EMA-derived NA scores in bivariate analyses (r 
= .025, p = .63), and in multivariate models adjusted for demographics (β = .011, p = .83). and 
lifestyle factors (β = -.010. p = .81). Analyses of this combined dataset were repeated with the 
inclusion of study phase (AHAB-1 vs. AHAB-2) as a covariate and produced virtually identical 
results. 
3.3 AIM 2: DOES GR-9Β GENOTYPE COVARY WITH MEASURES OF 
INFLAMMATION? 
3.3.1 GR-9β & stimulated cytokines 
Among the sample with stimulated cytokine data, 362 individuals (98%) were successfully 
genotyped. The GR-9β minor G allele was found at a frequency of 17%, and the distribution of 
genotypes conformed to Hardy Weinberg equilibrium (GG = 10, GA = 102, AA = 250, p > .05).  
To assess associations of GR-9β genotype with participant characteristics and cytokine 
production, analyses were conducted using independent t-tests, chi-squared tests, and analysis of 
variance to compare (1) individuals with the GG genotype to those with GA and AA genotypes, 
(2) individuals with the GG and GA genotypes to the AA genotype, and (3) all three genotypes 
in an additive G allele model. Results of these analyses are presented in Table 6. None of the 
demographics characteristics (age, gender, years of school) varied significantly as a function of 
GR-9β genotype (Table 6). Of the lifestyle factors, subjects homozygous for the A allele 
consumed more alcoholic beverages per week prior to study entry t(359) = 2.19, p < .05. 
However, no other lifestyle factor (BMI, physical activity, current smoking status) differed as a 
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function of GR-9β genotype. There were no differences across the GR-9β genotypes in scores on 
the NA measures (NEO Neuroticism, PANAS NA, or EMA NA; Table 6).  In Aim 2, it 
was hypothesized that stimulated production of proinflammatory cytokines would vary as a 
function of GR-9β genotype. Analyses examining stimulated production of IL-6, IL-1β, TNF-α, 
IL-8 across the genotype groups provided no support for this hypothesis (Table 6).  Individuals 
with the GG genotype were not significantly different from those with the alternate genotypes. 
Similarly, no significant associations of genotype with cytokine production were observed in 
multivariate models that controlled for demographic characteristics and lifestyle factors (Table 
7). 
3.3.2 GR-9β & circulating IL-6 
Of the 1,237 individuals with reliable IL-6 data, 1,208 were successfully genotyped (98%). In 
this sample, the G allele was observed at a frequency of 18%, and again the distribution of 
genotypes conformed to Hardy Weinberg equilibrium (GG=43, GA=338, AA=827; p>.05). 
Analyses were conducted as described for the stimulated cytokine sample, using a series of 
independent t-tests, chi-squared tests, and analysis of variance to compare participant 
characteristics and circulating levels of IL-6 among (1) the GG group compared to the other 
genotypes, (2) the GG and GA group compared the AA genotype, and (3) the 3 separate 
genotype groups in an additive G allele model (GG, GA, AA).  Results are presented in Table 8 
and show no significant difference in demographic or lifestyle factors, or NA (NEO Neuroticism 
or PANAS NA) as a function of GR-9β genotype. 
 Aim 2 also hypothesized that GR-9β G allele homozygotes would display elevated levels 
of circulating IL-6 as compared to other genotypes. Consistent with this possibility, a marginal 
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effect of G allele homozygosity emerged, with G allele homozygotes tending to show higher 
levels of circulating IL-6 than individuals of alternate genotypes t(1026) = 1.85, p = .065 (Table 
8). In hierarchical regression models that controlled for age, gender, and years of school, this 
trend reached statistical significance (β = .057, p = .045, R2 = .047). However, the effect was not 
significant in the full model that added lifestyle factors (BMI, physical activity, current smoking 
status, and alcohol use (β = .033, p = .238, R2 = .194). Although these analyses raise the 
possibility that lifestyle factors contribute to the association of GR-9β G allele homozygosity and 
increased IL-6 levels, in isolation, none of these lifestyle charactierstics sigificantly attenuated 
this association. These results remained significant after inclusion of study phase (AHAB-1 vs. 
AHAB-2) as a covariate. 
3.4 AIM 3: DOES GR-9Β GENOTYPE MODERATE ASSOCIATIONS OF NA AND 
INFLAMMATION? 
In Aim 3, it was hypothesized that GR-9β genotype would moderate associations of NA and 
peripheral cytokine activity, with GR-9β G allele carriers showing greater inflammatory 
susceptibility to negative emotionality. To address this possibility, an interaction term was 
entered into the final step of regression models that included NA scores and GR-9β genotype 
terms as main-effects. Results are shown in Tables 9-11, which display results of models 
comparing (1)GG vs. GA+AA, (2) GA+GA vs. AA, and (3) additive G alleles, respectively. 
 In support of the hypothesis, on analysis of stimulated IL-1β, a marginally significant 
interaction of PANAS NA and GR-9β G allele homozygosity emerged in unadjusted models (β = 
.106, p = .06, ∆R2 = .011) (Table 9). This interaction reached significance after controlling for 
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demographics (β = .120, p = .032, ∆R2 = .014), and persisted after subsequent adjustment for 
lifestyle factors (β = .127, p = .027, ∆R2 = .015). When stratified by GR-9β genotype, a positive 
association of PANAS NA and stimulated IL-1β was observed among GR-9β G allele 
homozygotes (r = .631, p < .05), but this association was non-significant among GA and AA 
individuals (r = -.050, p > .05) (Figure 1). 
An interaction of NA with GR-9β genotype was also observed on analysis of TNF-α 
production. However, here, the interaction was between NEO Neuroticism and GR-9β A allele 
homozygosity. This interaction term was significant in unadjusted models (β = -.141, p = .038, 
∆R2 = .014), but did not persist after controlling for demographics (β = -.113, p = .089, ∆R2 = 
.009) and lifestyle factors (β = -.110, p = .103, ∆R2 = .008). As shown in Figure 2, when stratified 
by GR-9β genotype, an unexpected inverse association of NEO Neuroticism and stimulated 
TNF-α emerged in the combined GG and GA group (r = -.233, p < .05) as compared to the AA 
group (r = -.020, p > .05). There was no significant interaction of NA with GR-9β genotype in 
the prediction of stimulated or circulating IL-6 or stimulated IL-8 levels (see Tables 9-11). 
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4.0  DISCUSSION 
It is widely suggested that dispositional NA is associated with an increase in systemic 
inflammation that confers risk for a range of chronic diseases of aging. The HPA axis is one 
biological pathway that may mediate associations of negative emotionality with inflammation, 
raising the possibility that individual differences in inflammatory susceptibility to HPA signaling 
may play a role. In this regard, it was hypothesized that the GR-9β polymorphism—the minor G 
allele of which confers a decrease in GC sensitivity—would moderate associations of NA and 
peripheral inflammation. More specifically, it was hypothesized that GR-9β G allele 
homozygotes would show increased susceptibility to affect-related elevations in inflammatory 
activity. The presented findings provide mixed support for this hypothesis. Consistent with our 
expectations, we observed a significant interaction of GR-9β G allele homozygosity and PANAS 
NA scores in the prediction of stimulated levels of IL-1β. To the extent that GG individuals 
reported greater levels of NA as assessed by the PANAS, they showed greater stimulated 
production of IL-1β—an association that was not observed among the GA and AA genotypes. 
These findings are consistent with the possibility that diminished GC-mediated signaling 
conferred by the GR-9β G allele resulted in resistance to the anti-inflammatory effects of GCs, 
and increased inflammation in the context of NA. For GR-9β  Α allele carriers, however, 
elevations in inflammation that accompany negative emotions may be down-regulated by intact 
GC-mediated anti-inflammatory signaling. 
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Although findings from the analysis of IL-1β are consistent with the possibility that GR-
9β G allele homozygotes show elevated inflammatory susceptibility to negative emotionality, 
this pattern was not observed on analysis of circulating levels of IL-6, or stimulated production 
of IL-8 or IL-6. Although a significant interaction of allele group and NA was observed on 
analysis of TNF-α production, the direction of effects was inconsistent with expectations. Here, 
G allele carriers showed lower levels of TNF-σ with increasing NA. However, this was a small 
effect that did not achieve significance once demographic characteristics were considered, which 
raises caution about its interpretation. Although TNF-α production may differ from the other 
cytokines investigated, it is also possible that this association is spurious, particularly given the 
number of analyses conducted. 
While the HPA system is speculated to play a role in associations of psychosocial risk 
factors and inflammation, other candidate pathways have been shown to link the central nervous 
and peripheral immune systems, and may also play a role in associations of negative affecitivty 
and inflammation. For example, it is well known that the sympathetic nervous system (SNS) 
modulates peripheral immune function, with stimulation of beta-adrenergic receptors on 
monocytes resulting in an upregulation of proinflammatory gene activity (see Irwin & Cole, 
2011). To the extent that negative emotions have been shown to modulate SNS activity, it is 
possible that the SNS and other psychophysiologic pathways operate in concert with the HPA 
axis in mediating associations of NA and inflammation. Thus, the lack of consistency in the 
current findings may be attributable to alternate biological pathways that play a greater role in 
associations of negative affectivity and inflammation. Future investigation into the genetic 
polymorphisms that confer inflammatory susceptibility within these systems is warranted, and 
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this approach may shed further light on the psychophysiologic processes involved in associations 
of negative emotionality and inflammation. 
Strategies for the detection of gene by environment interactions have been overviewed by 
Moffitt, Caspi, and Rutter (2005). Of relevance to the current study, Moffitt et al. (2005) suggest 
consulting quantitative behavioral-genetic models demonstrating heritability of the outcome of 
interest. In accordance with this notion, heritability estimates of circulating IL-6 have been 
previously shown to be 17-24%, while heritability estimates of LPS-stimulated IL-6, TNF-, and 
IL-1b are 57%, 53%, and 86%, respectively (de Craen et al., 2005). Second, Moffitt et al. (2005) 
suggest identifying a candidate environmental pathogen with a plausible effect on biological 
systems. As previously discussed, negative emotionality has been shown to activate the HPA 
axis and upregulate innate inflammatory activity, raising the possibility that GC-mediated 
signaling may mediate associations of negative affectivity and inflammation. Of noteworthy 
consideration, Moffitt et al., (2005) also raise the importance of optimizing risk measurements by 
selecting environmental measures that are proximal to the outcome of interest. In this regard, the 
current study focused on trait negative emotionality. However, no overall association of trait NA 
with the inflammatory measures was observed. It is possible that a measure of emotional state 
taken at the time of the blood draw may have shown stronger associations with inflammation. 
Alternatively, future investigation should consider the possibility that unique aspects of specific 
negative emotions, such as hostility or anxiety are more closely related to inflammation than 
their shared variance.  
The existing literature provides mixed support for an association of trait NA with 
systemic inflammation. To date, three studies of neuroticism have shown positive associations 
with IL-6. First, in a population-based study of 4923 Italians age 14-102 years, Sutin et al. (2010) 
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found that higher Neuroticism scores on the Revised NEO Personality Inventory, were related to 
elevated levels of IL-6. Similarly, Mottus, Luciano, Starr, Pollard, and Deary (2013) observed an 
association of Neuroticism scores on the NEO Five Factor Inventory (NEO-FFI), with higher IL-
6 levels during a 3-year follow-up of a British cohort of 592 individuals aged 70 years. Finally, 
in a cross-sectional study of 666 individuals, Millar et al. (2013) showed a positive association of 
IL-6 with neuroticism scores on the Eysenck Personality Questionnaire, particularly among low 
SES participants. Although these studies provide some evidence for an association between a 
global construct of NA and circulating IL-6 levels, several others, including the current study, 
find no or even inverse associations. For example, Nabi et al. (2008) found no association 
between IL-6 and Negative Affectivity on the Bradburn Affect-Balance Scale among 6396 
individuals participating in the Whitehall II Study. Similarly, Chapman et al. (2011) found no 
evidence of a relationship between NEO-FFI Neuroticism scores and IL-6 over a 34-week 
follow-up period in a sample of 200 older adults. Finally, a recent study of 1054 individuals 
living in the American Midwest found an unexpected inverse association of Neuroticism with 
circulating IL-6 levels (Turiano, Mroczek, Moynihan, & Chapman, 2013). It is possible that 
inconsistent findings indicate lack of an association, however, it is also possible that 
heterogeneity of sample characteristics across studies may obscure otherwise significant 
associations, which are typically small in magnitude. 
In addition to hypothesizing that NA would be associated with a marker of systemic 
inflammation, the current study also examined markers of inflammatory response. Here, it was 
hypothesized that dispositional negative affect would be associated with increased LPS-
stimulated production of proinflammatory mediators. Contrary to expectations and the existing 
literature (Bouhuys et al., 2004), we did not observe any significant associations of negative 
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affectivity, as measured by using standard questionnaires or ecological momentary assessment, 
with stimulated production of IL-6, IL-1β, TNF-α, or IL-8. These results are inconsistent with an 
emerging literature linking specific negative emotional dispositions to higher proinflammatory 
cytokine production. Reasons for discrepant findings are unclear; however, it is possible that 
results may vary as a function of distinct affective elements, rather than their shared affective 
variance. For example, several studies show positive associations of hostile dispositions with 
stimulated production of proinflammatory cytokines (Janicki-Deverts, Cohen, & Doyle, 2010; 
Marsland et al., 2007; Mommersteeg, Vermetten, Kavelaars, Geuze, & Heijnen, 2008; Suarez, 
Lewis, Krishnan, & Young, 2004; Suarez, Lewis, & Kuhn, 2002). In contrast, findings from 
studies investigating stimulated production and depression are largely mixed (e.g. Cyranowski et 
al., 2007; Suarez, Krishnan, & Lewis, 2003; Suarez et al., 2004). It is possible that 
inconsistencies across studies reflect heterogeneity of specific emotional constructs, with results 
varying as a function of different affective, attitudinal, and expressive elements. In this regard, 
the global construct of NA assessed in the current study may not have adequately addressed the 
specificity of emotions involved in the upregulation of inflammatory processes. Thus, further 
investigation into the individual emotions comprising negative affectivity is warranted, and may 
yield more positive findings, particularly in the case of hostile dispositions. 
Consistent with expectations, we found higher levels of circulating IL-6 among GR-9β G 
allele homozygotes in comparison to the GA and GG genotypes after adjustment for 
demographic factors. These results are consistent with findings from two previous studies (Otte 
et al., 2010; van den Akker et al., 2008), which also showed elevated markers of systemic 
inflammation among GG carriers. Taken together, these results complement molecular studies of 
GC-mediated signaling, where it is suggested that the GR-9β G allele results in stabilization of 
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GR-β mRNA, a splicing variant that fails to bind to cortisol and reduces the capacity for cortisol 
to elicit its typical gene-regulatory effects, including typical trans-repression of the pro-
inflammatory genes (Kino, Su, & Chrousos, 2009; Oakley & Cidlowski, 2011). Thus, our 
findings raise the possibility that elevated IL-6 levels observed among G allele homozygotes are 
explained by an attenuation in anti-inflammatory signaling typically imparted by the HPA 
system and cortisol release. The current findings lend further support to the possibility that GR-
9β genotype confers an elevation in systemic inflammation, which may, in turn, contribute to 
increased risk for chronic inflammatory disease. 
In contrast to the elevated levels of circulating IL-6 observed among GR-9β G allele 
homozygotes, the current findings showed no association of GR-9β genotype with stimulated 
production of IL-6, IL-1β, ΤΝF-α and IL-8 levels.  To our knowledge, this is the first study to 
investigate associations of GR-9β with stimulated cytokine production. It is possible that null 
findings relate to the in vitro stimulation approach utilized in the current study. Although the 
expression of proinflammatory cytokines in peripheral leukocytes is largely contingent on 
localized factors, integration of systemic signaling conferred by the HPA and sympathetic 
nervous systems is widely acknowledged to modulate the magnitude of immune responses. 
While the stimulated cytokine method utilized in the current study provides a clearer assessment 
of leukocyte-derived proinflammatory activity as compared to systemic IL-6 levels, this in vitro 
response reflects an artificially induced state of immune reactivity in the absence of systemic 
regulation. Given that the GR-9β polymorphism likely moderates inflammatory activity in the 
face of HPA axis activation and cortisol release, it is possible that the observed findings are 
attributable to the separation of blood leukocytes from HPA signaling resulting from the ex-vivo 
methodology. Supporting this notion, a study by van den Akker et al. (2006) showed that 
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elevations in inflammatory activity observed in GR-9β G allele homozygotes were observed only 
in the presence of dexamethasone, a synthetic analogue of cortisol with similar anti-
inflammatory properties. Quantification of cytokine activity following co-incubation of blood 
leukocytes with a range of cortisol levels likely provides a more direct assessment of GC 
sensitivity (see Burnsides et al., 2012), and this approach may shed light on potential differences 
in inflammatory activity in GR-9β G allele carriers. 
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5.0  LIMITATIONS 
There are several noteworthy limitations of the current study that warrant attention in future 
investigations. First, the cross-sectional design was limited to single assessments of circulating 
IL-6 and stimulated cytokine levels. While these assessments are relatively stable over time, a 
more reliable indicator of inter-individual variability in inflammatory activity may be derived by 
aggregating across multiple assessment occasions. Second, the methodology utilized to assess 
acute infection differed across both phases of the AHAB Study. While participants were actively 
screened for acute illness in AHAB-2, this proceedure was not conducted in AHAB-1, and thus 
participants with IL-6 concentrations above 10 pg/mL were excluded from analyses. It is 
possible this proceedure may have obscured associations of negative affectivity and circulating 
IL-6 levels, further contributing to our null results. Third, analyses in the current study were 
limited to a sub-sample of individuals of European-American ancestry, limiting the 
generalizability of our findings to other ethnic populations.  
In genetic analyses, we observed significant interactions of GR-9β and negative 
affectivity in the prediction of stimulated IL-1β and TNF-α. However, directionality of these 
interactions differed between cytokines, and given the number of models analyses conducted, the 
possibility of Type 1 Error should be considered. Finally, the current study investigated a SNP 
located in NR3C1 gene previously associated with increased systemic inflammation. It is 
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possible that associations of NA and inflammation may have been moderated by other functional 
variants located in NR3C1. 
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6.0  SUMMARY AND FUTURE DIRECTIONS 
Although it is speculated that genetic variaiblity may play a role in physiologic susceptibility to 
psychosocial risk factors, few empirical studies have  investigated this possibility. The current 
study utilized a candidate gene approach and found limited evidence that the GR-9β G allele, 
previously associated increased levels of systemic inflammation, moderated associations of 
negative emotionality and inflammatory activity. Although the HPA system may play a role in 
associations of psychosocial risk factors and inflammation, the psychologically-elicited 
modulation of inflammatory processes is likely reflective of an intricate process, involving both 
the integration and interaction of several systems. In this regard, future studies investigating 
genetic variants conferring inflammatory sensitivity to other intermediary psychobiological 
pathways, including the autonomic nervous system, are warranted. To the extent that the 
psychological specificity of negative emotions may play a role in the upregulation of 
inflammatory processes, future studies should also consider assessing individual negative affects. 
The proximity of these emotions may also increase the likelihood of uncovering gene-
environment interactions. 
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7.0  TABLES & FIGURES 





AHAB-1 Mean (SD) AHAB-2 Mean (SD) AHAB-1 vs. AHAB-2
Age (years) 44.7 (6.8) 42.4 (7.3) t(1235)= 5.43**
Gender (% female) 51.2 51.1 χ1
2
<1
Years in school 16.0 (2.3) 17.1 (2.8) t(1235)= 6.57**
BMI 27.1 (5.4) 26.4 (5.0) t(1235)= 1.91
Weekly kilocalorie expenditure 12326.7 (1780.3) 2772.6 (2041.1) t(1235)= 2.70**
% Currently smoking 13.0 11.3 χ1
2
<1
# Alcoholic beverages in past week 4.1 (7.8) 3.4 (4.8) t(1048)= 1.50
* = p<.05
**=p<.01
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Table 2. Bivariate correlations between stimulated cytokine levels, negative affect measures, demographics, and lifestyle factors in the AHAB-2 sample. 
 
  
Mean (SD) IL-6 IL-1β TNFα IL-8 NEO Neuroticism PANAS EMA Age Gender Years in school BMI Weekly kilocalories Smoking # Alcoholic beverages Sleep Quality
Stimulated IL-6 (pg/mL) 51306 (35461) -- .582** .590** .140* -.064 -.013 -.054 -.159** -.256** .032 .019 .010 .087 .063 .004
Stimulated IL-1β (pg/mL) 12110 (7558) -- -- .795** -.182** -.020 -.021 -.072 -.146** .032 .053 -.057 .040 -.010 -.018 -.070
Stimulated TNF-α (pg/mL) 7222 (6155) -- -- -- -.200** -.047 -.040 -.064 -.180** -.144** .084 -.105 .053 -.013 -.094 -.021
Stimulated IL-8 (pg/mL) 679749 (2870583) -- -- -- -- -.031 .062 -.027 .009 -.140* -.132* .126* -.076 .140* .063 .022
Negative Affectivity
NEO Neuroticism 74.86 (23.20) -- -- -- -- -- .664** .355** -.069 .052 -.100 -.007 -.065 .120* .059 .328**
PANAS Negative Affect 15.53 (5.15) -- -- -- -- -- -- .340** .047 -.097 .017 -.014 -.033 .128* .151** .313**
EMA Negative Affect 1.89 (0.71) -- -- -- -- -- -- -- .034 -.035 -.049 .066 -.051 .119* .126* .206**
Age (years) 42.81 (7.37) -- -- -- -- -- -- -- -- .142** -.051 .095 -.019 .045 .051 .052
Gender (% female) 52.2 -- -- -- -- -- -- -- -- -- -.148** -.089 -.042 -.016 -.121* -.052
Years in school 17.00 (2.96) -- -- -- -- -- -- -- -- -- -- -.146** .156** -.144** .016 -.061
BMI 26.94 (5.19) -- -- -- -- -- -- -- -- -- -- -- -.200** .103* .048 .090
Weekly kilocalorie expenditure 2753.11 (2108.71) -- -- -- -- -- -- -- -- -- -- -- -- -.072 -.066 -.103*
% Currently smoking 14.1 -- -- -- -- -- -- -- -- -- -- -- -- -- .180** .097
# Alcoholic beverages in past week 2.99 (4.29) -- -- -- -- -- -- -- -- -- -- -- -- -- -- .203**
* = p<.05
**=p<.01
Stimulated Cytokine Levels Negative Affectivity Measure Demographics and Lifestyle Factors
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Table 3. Results of hierarchical regression analyses examining associations between negative affect measures and stimulated cytokine concentrations 













NEO Neuroticism -.067 .216 .086 -.034 .547 .030 -.054 .333 .057 -.046 .435 .050
PANAS Negative Affect -.044 .412 .086 -.028 .610 .027 -.069 .210 .056 .043 .464 .046
EMA Negative Affect Score -.066 .215 .089 -.062 .262 .028 -.062 .258 .056 -.050 .395 .034
ß p R
2
 Change ß p R
2
 Change ß p R
2
 Change ß p R
2
 Change
NEO Neuroticism -.089 .130 .007 -.023 .709 .000 -.052 .377 .002 -.059 .352 .003
PANAS Negative Affect -.068 .231 .004 -.020 .734 .000 -.064 .269 .004 .036 .559 .001




 Each NA measure was entered in a separate model.
b 
Covariates entered in this step of the regression equation: age, gender, and years of education.
c 
Covariates entered in this step of the regression equation include those entered in Model 3 in addition to BMI, physical activity, current smoking status, and weekly alochol use.
Stimulated IL-6 (n=332) Stimulated IL-1β (n=336) Stimulated TNF-α (n=333) Stimulated  IL-8 (n=292)
Model 1 
b
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Table 4. Bivariate correlations between circulating IL-6, negative affect measures, demographics, and lifestyle factors in the combined AHAB sample. 
 
  
Mean (SD) IL-6 NEO Neuroticism PANAS Age Gender Years in school BMI Weekly kilocalories Smoking # Alcoholic beverages
Circulating IL-6 concentration (pg/mL) .50 (.16) -- .038 -.023 .134** .050 -.160** .349** -.178** .105** .039
--
Negative Affectivity --
NEO Neuroticism 74.84 (23.54) -- -- .654** -.119** .057* -.120** .064* -.099** .068* .065*
PANAS Negative Affect 14.97 (5.12) -- -- -- -.113** -.065* .009 .040 -.048 .064* .138**
-- -- --
Age (years) 44.09 (7.09) -- -- -- -- -.088** .060* -.054 -.004 .034
Gender (% female) 51.2 -- -- -- -- -- -.089** -.161** -.064* -.026 -.212**
Years in school 16.38 (2.83) -- -- -- -- -- -- -.096** .123** -.140** -.018
BMI 26.89 (5.32) -- -- -- -- -- -- -- -.165** -.027 .004
Weekly kilocalorie expenditure 2558.7 (1864.9) -- -- -- -- -- -- -- -- -.090** .057
% Currently smoking 12.5 -- -- -- -- -- -- -- -- -- .206**
# Alcoholic beverages in past week 3.88 (6.89) -- -- -- -- -- -- -- -- -- --
* = p<.05
**=p<.01
Negative Affectivity Measure Demographics and Lifestyle Factors
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Table 5. Results of hierarchical regression analyses examining associations between negative affect measures and circulating IL-6 concentration after 





NEO Neuroticism .040 .158 .046
PANAS Negative Affect -.013 .647 .047
NEO Neuroticism .017 .548 .194
PANAS Negative Affect -.015 .593 .197
a
 Each NA measure was entered in a separate model.
b 
Covariates entered in this step of the regression equation: age, gender, and years of education.
c 






  43 
Table 6. Univariate participant characteristics by GR-9β genotype in the AHAB-2 stimulated cytokine sample. Absolute T-values are reported. 
  
GG vs. GA+AA GG+GA vs. AA GG vs. GA vs. AA
Demographic Fators
Age (years) t360=1.56 t360<1 F2,359=1.32







Years in school t360=1.37 t360<1 F2,359<1
Lifestyle Factors
BMI t360<1 t360<1 F2,359<1








# Alcoholic beverages in past week t359<1 t359=2.19* F2,358=2.41
Negative Affect Measures
NEO Neuroticism t357<1 t359=1.72 F2,356=1.48
PANAS Negative Affect t359<1 t359<1 F2,358<1
EMA Negative Affectivity t356=1.06 t356<1 F2,355<1
LPS-stimulated Cytokine Production
Stimulated IL-6 t325<1 t325<1 F2,324<1
Stimulated IL-1β t323<1 t323<1 F2,322<1
Stimulated TNF-α t321<1 t321<1 F2,320<1
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Table 7. Results of regression analyses examining associations between GR-9β genotype and stimulated cytokine concentrations after controlling for 
demographic and lifestyle factors in the AHAB-2 sample. 
 
  












GG vs. GA+AA 
b
.068 .209 .086 .059 .292 .036 -.027 .627 .049 -.045 .446 .052 .057 .045 .047
GA+GG vs. AA 
c
.058 .280 .084 .013 .813 .033 .023 .675 .049 .010 .866 .050 .032 .257 .045
Additive 
d
.072 .180 .086 .030 .585 .033 .011 .839 .049 -.005 .937 .050 .046 .100 .043
Model 2 
g
GG vs. GA+AA 
b
.068 .213 .093 .062 .272 .040 -.028 .614 .070 -.052 .371 .077 .033 .238 .194
GA+GG vs. AA 
c
.058 .284 .092 .016 .781 .037 .015 .787 .070 .000 .994 .074 .018 .516 .194
Additive 
d





Covariates entered in this step of the regression equation include those entered in Model 1 in addition to BMI, physical activity, current smoking status, and weekly alochol use.
Stimulated IL-6 (n=332) Stimulated IL-1β (n=330) Stimulated TNF-α (n=327) Stimulated IL-8 (n=292)
a 
Reported values correspond to genotype codes that were created for recessive, dominant, and additve modes of genetic influence.
b
 AA, GA, and GG genotypes were coded as 0, 0, and 1 respectively.
c
 AA, GA, and GG genotypes were coded as 0, 1, and 1 respectively.
d
 AA, GA, and GG genotypes were coded as -1, 0, and 1 respectively.
e 
Covariates entered in this step of the regression equation: age, gender, and years of education
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Table 8. Univariate participant characteristics by GR-9β genotype in the combined AHAB sample. Absolute T-values are reported. 
 
GG vs. GA+AA GG+GA vs. AA GG vs. GA vs. AA
Demographic Factors
Age (years) t1206<1 t1206<1 F2,1205<1







Years in school t1206<1 t1206<1 F2,1205<1
Lifestyle Factors
BMI t1204<1 t1204<1 F2,1203<1
Weekly kilocalorie expenditure t1203<1 t1203<1 F2,1202<1







# Alcoholic beverages in past week t1028<1 t1028=1.77 F2,1027=1.58
Negative Affect Measures
NEO Neuroticism t1198<1 t1198<1 F2,1197<1
PANAS Negative Affect t1197<1 t1197<1 F2,1196<1
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Table 9. Results of regression analyses examining interactions between rs6198 genotype and NA measures predicting stimulated cytokines and systemic 
IL-6, after adjustment for demographic characteristics and lifestyle factors. GG, GA, and AA genotypes were coded 
 
  
ß SE p ß SE p ß SE p ß SE p ß SE p
Unadjusted models
NEO Neuroticism X GG vs. GA+AA -.016 .005 .778 .020 .614 .721 .039 .616 .495 .005 .008 .936 -.004 .001 .881
PANAS Negative Affect X GG vs. GA+AA .047 .021 .402 .106 2.730 .062 .074 2.759 .192 .022 .041 .717 -.012 .005 .681
EMA Negative Affect X GG vs. GA+AA .014 .134 .822 .046 16.952 .445 .074 17.181 .225 -.046 .279 .486 -- -- --
NEO Neuroticism X GG vs. GA+AA -.034 .005 .533 .039 .610 .493 .042 .607 .464 -.027 .008 .649 -.020 .001 .488
PANAS Negative Affect X GG vs. GA+AA .041 .021 .453 .120 2.702 .032 .080 2.708 .154 -.001 .040 .984 -.017 .005 .549
EMA Negative Affect X GG vs. GA+AA .005 .128 .935 .052 16.806 .387 .073 16.866 .222 -.053 .274 .411 -- -- --
Model 3 
b
NEO Neuroticism X GG vs. GA+AA -.024 .005 .668 .049 .629 .407 .042 .621 .472 -.005 .008 .930 -.014 .001 .632
PANAS Negative Affect X GG vs. GA+AA .053 .021 .341 .127 2.774 .027 .078 2.754 .167 .019 .041 .747 .009 .005 .750
EMA Negative Affect X GG vs. GA+AA .007 .130 .908 .052 17.105 .395 .066 17.021 .271 -.029 .281 .662 -- -- --
a 
Covariates in this model include age, gender, and years of education,  
b 




Stimulated IL-6 (n=332) Stimulated IL-1β (n=330) Stimulated TNF-α (n=327) Stimulated IL-8 (n=292)
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Table 10. Results of regression analyses examining interactions between rs6198 genotype and NA measures predicting stimulated cytokines and 
systemic IL-6, after adjustment for demographic characteristics and lifestyle factors. GG, GA, and AA genotypes were coded 
 
  
ß SE p ß SE p ß SE p ß SE p ß SE p
Unadjusted models
NEO Neuroticism X GG+GA vs. AA -.113 .001 .092 -.071 .177 .284 -.141 .178 .038 .046 .002 .526 .055 .000 .113
PANAS Negative Affect X GG+GA vs. AA -.040 .006 .537 .008 .832 .901 -.069 .842 .294 -.018 .012 .796 .039 .002 .264
EMA Negative Affect X GG+GA vs. AA -.129 .045 .056 -.035 5.714 .608 -.051 5.820 .454 -.068 .080 .351 -- -- --
NEO Neuroticism X GG+GA vs. AA -.086 .001 .187 -.069 .176 .303 -.113 .175 .089 .054 .002 .446 .037 .000 .278
PANAS Negative Affect X GG+GA vs. AA -.027 .006 .664 .006 .824 .929 -.064 .825 .319 -.004 .011 .957 .031 .002 .376
EMA Negative Affect X GG+GA vs. AA -.112 .043 .083 -.023 5.679 .734 -.037 5.712 .584 .076 .078 .289 -- -- --
Model 3 
b
NEO Neuroticism X GG+GA vs. AA -.085 .001 .199 -.063 .179 .352 -.110 .177 .103 .054 .002 .453 .033 .000 .325
PANAS Negative Affect X GG+GA vs. AA -.029 .006 .654 -.030 .399 .614 -.069 .836 .292 -.007 .012 .924 .023 .002 .504
EMA Negative Affect X GG+GA vs. AA -.115 .043 .081 -.019 5.769 .784 -.036 5.753 .598 -.081 .079 .259 -- -- --
a 
Covariates in this model include age, gender, and years of education,  
b 




Stimulated IL-6 (n=332) Stimulated IL-1β (n=330) Stimulated TNF-α (n=327) Stimulated IL-8 (n=292)
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Table 11. Results of regression analyses examining interactions between rs6198 genotype and NA measures predicting stimulated cytokines and 
systemic IL-6, after adjustment for demographic characteristics and lifestyle factors. GG, GA, and AA genotypes were coded 
 
  
ß SE p ß SE p ß SE p ß SE p ß SE p
Unadjusted models
NEO Neuroticism X Additive G Allele -.107 .001 .106 -.075 .161 .263 -.114 .163 .090 .042 .002 .555 .056 .000 .208
PANAS Negative Affect X Additive G Allele -.022 .006 .739 .039 .750 .546 -.037 .760 .566 -.010 .011 .880 .037 .002 .409
EMA Negative Affect X Additive G Allele -.107 .039 .109 -.012 5.019 .855 -.027 5.105 .693 -.079 .072 .271 -- -- --
NEO Neuroticism X Additive G Allele -.089 .001 .167 -.051 .160 .440 -.089 .160 .178 .039 .002 .574 .029 .000 .516
PANAS Negative Affect X Additive G Allele -.012 .006 .842 .041 .742 .522 -.032 .744 .617 -.004 .010 .951 .025 .002 .574
EMA Negative Affect X Additive G Allele -.094 .038 .142 .001 4.989 .985 -.012 5.012 .851 -.088 .071 .210 -- -- --
Model 3 
b
NEO Neuroticism X Additive G Allele -.085 .001 .192 -.044 .164 .516 -.087 .163 .194 .046 .002 .516 .030 .000 .505
PANAS Negative Affect X Additive G Allele -.010 .006 .876 .050 .761 .451 -.037 .756 .570 -.001 .011 .988 .030 .002 .496
EMA Negative Affect X Additive G Allele -.095 .038 .142 .005 5.059 .941 -.013 5.042 .844 -.087 .072 .222 -- -- --
a 
Covariates in this model include age, gender, and years of education,  
b 




Stimulated IL-6 (n=332) Stimulated IL-1β (n=330) Stimulated TNF-α (n=327) Stimulated IL-8 (n=292)
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Figure 1. Stimulated IL-1β values estimated from the interaction of GR-9β genotype and PANAS Negative Affect scores. 
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Figure 2. Stimulated TNF-α values from the interaction of GR-9β genotype and PANAS Negative Affect scores. 
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